作者: James L. Novakoff
DOI:
关键词:
摘要: The present invention relates to processes and methods for undertaking clinical trials using pharmacogenomics-based techniques. In particular, the collection of circulating RNA in an individual or group individuals before after event intervention, identifying any changes such intervention relating change but without need identification protein which codes; levels these transcripts assess disease progression, remission, therapeutic effect, development new treatments.